Skip to main content

Table 3 Correlations between CXCL8 expression and clinic-pathological features of 75 ADC patients in immunohistochemistry chip (HLug-Ade150Sur-02)

From: DACH1 antagonizes CXCL8 to repress tumorigenesis of lung adenocarcinoma and improve prognosis

Variables N CXCL8 expression P value
≤ 8 (low expression) > 8 (high expression)
Age     0.865a
 < 55 20 14 6  
 ≥ 55 53 36 17  
Sex     0.255a
 Male 40 30 10  
 Female 35 22 13  
Grade     0.249b
 1~ 2 61 40 21  
 3 14 12 2  
Stage     0.024a
 I~II 40 30 10  
 III 18 8 10  
Lymph node     
 N− 36 29 7 0.004a
 N+ 21 9 12  
Tumor size     
 T1–T2 60 45 15 0.069b
 T3–T4 15 7 8  
  1. aPearson chi-square test
  2. bContinuity correction chi-square test